Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name PI Organization Sort ascending Title Grant Number Initiative Program Official
Spiegel, Brennan

Cedars-Sinai Medical Center
United States

Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes 5R01CA252211-05 Rachel Altshuler, Ph.D.
Buszczak, Michael

Ut Southwestern Medical Center
United States

Developing ribosome biogenesis inhibitors for the prevention of cancer 5UG3CA290312-02 Kajal Biswas, Ph.D.
Groninger, J. Hunter

Medstar Health Research Institute
United States

Cognitive behavioral theory-assisted virtual reality for chronic cancer pain (VR-CAN): device prototype development and feasibility testing 1R21CA299799-01 Brennan Streck, Ph.D., RN, M.P.H.
Salvemini, Daniela

Saint Louis University
United States

Fingolimod and Ozanimod for the treatment and prevention of chemobrain 5R01CA261979-04 Rachel Altshuler, Ph.D.
Vijayvergia, Namrata

Research Inst Of Fox Chase Can Ctr
United States

Exploring the Neuroprotective Potential of CBD in Preventing Oxaliplatin-Induced Neuropathy: A Prospective Study 1R21CA292276-01A1 Rachel Altshuler, Ph.D.
Eastham, James A

Sloan-Kettering Inst Can Research
United States

Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers 5U01CA266535-04 PAR-18-913 (U01 Clinical Trial Not Allowed) Claire Zhu, Ph.D.
Semmes, Oliver John

Old Dominion University
United States

Virginia-UCLA-Toronto Biomarker Characterization Center 5U2CCA271894-05 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Rosenbluth, Jennifer M.

University Of California, San Francisco
United States

In vitro models as a window to learn how to change outcomes in women at high risk of developing breast cancer 4R01CA281361-04 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Staff, Nathan P

Mayo Clinic Rochester
United States

Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity 5R01CA275870-04 PAR-21-329 (R01 Clinical Trial Optional) Rachel Altshuler, Ph.D.
Rosser, Charles J

Cedars-Sinai Medical Center
United States

A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology 5R01CA277810-03 Guillermo Marquez, Ph.D.